Might be old news to some. Double hor... - Fight Prostate Ca...

Fight Prostate Cancer

3,020 members•1,456 posts

Might be old news to some. Double hormone blockage and triple

10 days ago•0 Replies

ARANOTE Trial Explores Darolutamide’s Role in High and Low-Volume Metastatic Prostate Cancer - Fred Saad

Things are moving quickly. Look at those response rates. In just a few years we've improved 3x re: ADT vs double hormone blockade. And darolutamide hasn't been around very long. Researchers are already developing gen 3 ARSIs.

Written by

PCaWarrior

To view profiles and participate in discussions please or .

Not what you're looking for?

Popular Posts

BAT with estrogen for ADT?

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.

Might be old news to some. Double hor... - Fight Prostate Ca...

Fight Prostate Cancer

Might be old news to some. Double hormone blockage and triple

Not what you're looking for?

You may also like...

Anyone on Nubeqa ? on triplicate therapy, Firmagon, Zytiga & Prednisone Started Docetaxel Chemotherapy no mention of Nubeqa DX 07/2022

Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer

Phase 1 recruiting: QXL138AM, for CD138 expressing tumors

Great update: 67Cu-SAR-bisPSMA gets fast tracked by FDA

? For fellow BATmen on daro and androgen stimulation. Great Article

Related Posts

Popular Posts